Delivering insightful advice on the buy-side and sell-side of transactions from 20 years of experience.
David has built a reputation in the industry for delivering insightful advice embedded in a deep understanding of transactions. He specialises in providing advice to corporate, private equity and high net worth clients on both the buy-side and sell-side of transactions.
David’s experience includes acquisition due diligence, sell-side assistance and vendor due diligence, integration and carve out, transaction management support and valuations. With a proven track record, David has worked with organisations across a broad range of industries, such as health and wellness, food and beverage, software, retail, leisure and gaming, transport and logistics, mining services, energy, manufacturing and financial services.
David has worked on several high-profile transactions, including, Newbridge Capital/Texas Pacific Group’s acquisition of Myer, L Capital Asia’s acquisition of RM Williams, Swisse Wellness’ sale to Biostime, the acquisition of a minority stake in endota spa and vendor due diligence in relation to the sale of a minority shareholding in Remedy Kombucha to Lion Dairy and Drinks. His valuations experience includes purchase price allocation advice for several groups – including Hoyts, MedAdvisor, Deep Blue Company, ToxFree, McAleese and Eternal Best Industries (EBI) and various valuation assignments for ASX and other Corporations Act requirements.
"Regardless of the industry or business size, the right advice, provided at the right time is key to successful deal-making."
Qualifications & memberships
Member, CA ANZ
Graduate Diploma of Applied Finance and Investment
Bachelor of Commerce, University of Melbourne